抗凝血疗法和对视网膜静脉封闭和眼内出血风险的影响 横跨美国大型国家数据库
Ophthalmic surgery, lasers & imaging retina
|June 17, 2025
概括
与华法林相比,直接口服抗凝剂 (DOAC) 显示视网膜静脉封闭 (RVO) 和眼内出血的风险较低. 这项大型美国研究表明,DOAC可能是抗凝固管理的更安全选择.
科学领域:
- 眼科医生 眼科 眼科
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 系统性抗凝血是高凝血状态的标准.
- 视网膜静脉封闭 (RVO) 的比较风险与直接口服抗凝剂 (DOACs) 与华法林的比较风险在美国大型队列中并不成熟.
研究的目的:
- 为了研究与华法林相比,用DOACs治疗的患者中RVO和眼内出血的风险.
主要方法:
- 使用大型ICD-10编码数据库进行回顾性队列研究.
- 倾向性得分匹配创造了对华法林或DOACs患者的可比组.
- 在以前没有RVO的患者中计算了RVO和眼内出血的风险比率.
主要成果:
- 与DOAC相比,华法林使用与新RVO诊断的风险显著增加有关 (RR:1.49).
- 受华法林治疗的患者患玻璃体出血 (RR: 2.14),视网膜出血 (RR: 1.84) 和胆道出血 (RR: 2.06) 的风险更高.
结论:
- 与华法林相比,直接口服抗凝剂 (DOAC) 与RVO和眼内出血的风险显著降低.
- 对于面临眼部并发症风险的患者来说,DOAC可能是一种更安全的抗凝策略.
相关概念视频
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis IV: Nursing Management
27
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
27
Anticoagulant Drugs: Low-Molecular-Weight Heparins
932
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
932
Venous Thrombosis I: Introduction
47
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
47
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
43
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
43


